HK1036454A1 - New aminopyrroline compounds, proces for their preparation and pharmaceutical compositions containing them. - Google Patents

New aminopyrroline compounds, proces for their preparation and pharmaceutical compositions containing them.

Info

Publication number
HK1036454A1
HK1036454A1 HK01107419A HK01107419A HK1036454A1 HK 1036454 A1 HK1036454 A1 HK 1036454A1 HK 01107419 A HK01107419 A HK 01107419A HK 01107419 A HK01107419 A HK 01107419A HK 1036454 A1 HK1036454 A1 HK 1036454A1
Authority
HK
Hong Kong
Prior art keywords
alkyl
new
compounds
aminopyrroline
proces
Prior art date
Application number
HK01107419A
Other languages
English (en)
Inventor
Pascal Bousquet
Jean-Daniel Ehrhardt
Veronique Bruban
Josiane Feldman
Stephan Schann
Elizabeth Scalbert
Bruno Pfeiffer
Pierre Renard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1036454A1 publication Critical patent/HK1036454A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK01107419A 1999-11-17 2001-10-24 New aminopyrroline compounds, proces for their preparation and pharmaceutical compositions containing them. HK1036454A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9914434A FR2801051B1 (fr) 1999-11-17 1999-11-17 Nouveaux composes aminopyrroline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
HK1036454A1 true HK1036454A1 (en) 2002-01-04

Family

ID=9552203

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01107419A HK1036454A1 (en) 1999-11-17 2001-10-24 New aminopyrroline compounds, proces for their preparation and pharmaceutical compositions containing them.

Country Status (23)

Country Link
US (1) US6300366B1 (zh)
EP (1) EP1101756B1 (zh)
JP (1) JP3274456B2 (zh)
KR (1) KR100453981B1 (zh)
CN (1) CN1158257C (zh)
AT (1) ATE234815T1 (zh)
AU (1) AU771745B2 (zh)
BR (1) BR0005442A (zh)
CA (1) CA2325781C (zh)
DE (1) DE60001706T2 (zh)
DK (1) DK1101756T3 (zh)
EA (1) EA004042B1 (zh)
ES (1) ES2194691T3 (zh)
FR (1) FR2801051B1 (zh)
HK (1) HK1036454A1 (zh)
HU (1) HUP0004543A3 (zh)
MX (1) MXPA00011239A (zh)
NO (1) NO317987B1 (zh)
NZ (1) NZ508228A (zh)
PL (1) PL343920A1 (zh)
PT (1) PT1101756E (zh)
SI (1) SI1101756T1 (zh)
ZA (1) ZA200006731B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003257418A1 (en) 2002-06-19 2004-01-06 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
GB0521083D0 (en) * 2005-10-17 2005-11-23 Novartis Ag Organic compounds
NZ717739A (en) 2013-08-09 2023-12-22 Ardelyx Inc Compounds and methods for inhibiting phosphate transport
GB201318886D0 (en) * 2013-10-25 2013-12-11 Givaudan Sa Improvements i or relating to organic compounds
CN114716359B (zh) * 2022-04-28 2023-01-17 广东医科大学 一种氢化吲哚亚胺非对映异构体的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2029297A1 (de) * 1970-06-13 1971-12-30 Farbenfabriken Bayer Ag, 5090 Leverkusen Neue Aminophenyl-cycloamidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US3887569A (en) * 1970-10-30 1975-06-03 Mcneilab Inc 2-Imino-piperidines
NL7412695A (nl) * 1974-09-26 1976-03-30 Stamicarbon De bereiding van een 2-amino-pyrrolinederivaat.
US4579951A (en) * 1984-03-19 1986-04-01 G. D. Searle & Co. Substituted (azacycloalk-2-yl)iminophenols and esters thereof
DE4425070A1 (de) * 1994-07-15 1996-01-18 Degussa Verfahren zur Herstellung optisch aktiver l-substituierter 2-(Aminomethyl)pyrrolidine

Also Published As

Publication number Publication date
CN1298872A (zh) 2001-06-13
KR100453981B1 (ko) 2004-10-20
EA200001077A2 (ru) 2001-06-25
MXPA00011239A (es) 2002-05-23
EA200001077A3 (ru) 2001-08-27
DE60001706T2 (de) 2004-02-05
ATE234815T1 (de) 2003-04-15
NO20005797D0 (no) 2000-11-16
CA2325781C (fr) 2006-07-18
EP1101756B1 (fr) 2003-03-19
AU7168000A (en) 2001-05-24
NZ508228A (en) 2001-03-30
US6300366B1 (en) 2001-10-09
NO317987B1 (no) 2005-01-17
EA004042B1 (ru) 2003-12-25
JP2001139545A (ja) 2001-05-22
CN1158257C (zh) 2004-07-21
NO20005797L (no) 2001-05-18
AU771745B2 (en) 2004-04-01
DK1101756T3 (da) 2003-07-14
DE60001706D1 (de) 2003-04-24
KR20010051776A (ko) 2001-06-25
PT1101756E (pt) 2003-06-30
EP1101756A1 (fr) 2001-05-23
HUP0004543A3 (en) 2001-11-28
HU0004543D0 (zh) 2001-02-28
ES2194691T3 (es) 2003-12-01
JP3274456B2 (ja) 2002-04-15
FR2801051A1 (fr) 2001-05-18
HUP0004543A2 (hu) 2001-10-28
PL343920A1 (en) 2001-05-21
CA2325781A1 (fr) 2001-05-17
BR0005442A (pt) 2001-07-03
FR2801051B1 (fr) 2001-12-14
SI1101756T1 (en) 2003-06-30
ZA200006731B (en) 2001-05-30

Similar Documents

Publication Publication Date Title
KR950014097A (ko) 피페라진 유도체
HUP9802694A1 (hu) Benzamidszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
IL134419A0 (en) Epothilone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
TW200724136A (en) Pharmaceutical compositions comprising PPAR modulator
AU6823590A (en) New (1-naphtyl)piperazine derivatives, process for preparing these and pharmaceutical compositions containing them
HK1036454A1 (en) New aminopyrroline compounds, proces for their preparation and pharmaceutical compositions containing them.
HUP0201475A2 (hu) Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
SE7501365L (zh)
EP1432709B8 (en) 1-glyoxylamide indolizines for treating cancer
HUP0303361A2 (hu) Helyettesített 1-amino-bután-3-ol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
TW200510309A (en) Chemical compounds
ZA9811645B (en) Acronycine compounds a process for their preparation and pharmaceutical compositions containing them
HUP9702149A2 (hu) Tachykinin receptor antagonista heterociklikus piperazinonszármazékok, intermedierjeik, előállításuk és alkalmazásuk, valamint a vegyületeket tartalmazó gyógyászati készítmények
HUP0204444A2 (en) Phenyl- and pyridyl-tetrahydro-pyridines, process for their preparation and pharmaceutical compositions containing them
IL85253A (en) 8-heteroaryl ergoline derivatives,their preparation and pharmaceutical compositions containing them
AU4440497A (en) New substituted 7,12-dioxabenz(a)anthracene compounds, process for preparing them and pharmaceutical compositions containing them
MXPA03010597A (es) Derivados de triciclicos de dihidroquinolinas proceso para prepararlos y composiciones farmaceuticas que los contienen.
HK1024244A1 (en) 8h-thieno-(2,3-b)pyrrolizin-8-one compounds, a process for their preir preparation and pharmaceutical compositions containing them
MXPA04011363A (es) Nuevos derivados acil hidrazino del tiofeno, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion.
HUP9902088A2 (hu) Szubsztituált 1,3-benzodioxol-származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
HUT57221A (en) Process for producing pyrrolo(2,1-b)thiazol derivatives and pahrmaceutical compositions contiaining them as active components

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20081117